Evidence map›Paper›PMID 40854629›Full record

ArticleJournal, genetic engineering & biotechnology2025

Profiling of proteases involved in SARS-CoV-2 pathogenesis in human saliva: Influence of age and gender.

Mentalla Motaz Abdellatif, Azza El Amir, Said Shalaby, Michael Kirschfink, Rola Nadeem, Dina Nadeem Abd-Elshafy, Mahmoud Mohamed Bahgat

Abstract read
In one paragraph

Article in Journal, genetic engineering & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mentalla Motaz AbdellatifDepartment of Therapeutic Chemistry, Institute of Pharmaceutical and Drug Industries Research, the National Research Centre, Dokki, Giza 12311, Egypt; Research Group Immune- and Biomarkers for Infection, the Centre of Excellence for Advanced Sciences, the National Research Centre, Giza 12311, Egypt.
Azza El AmirZoology Department, Faculty of Science, Cairo University, Giza 12613, Egypt.
Said ShalabyDepartment of Complementary and Alternative Medicine, Medical Research Division, National Research Centre, Dokki, 12622 Giza, Egypt.
Michael KirschfinkInstitute of Immunology, Ruprecht Karls University of Heidelberg, Heidelberg, Germany.
Rola NadeemDepartment of Therapeutic Chemistry, Institute of Pharmaceutical and Drug Industries Research, the National Research Centre, Dokki, Giza 12311, Egypt; Research Group Immune- and Biomarkers for Infection, the Centre of Excellence for Advanced Sciences, the National Research Centre, Giza 12311, Egypt.
Dina Nadeem Abd-ElshafyResearch Group Immune- and Biomarkers for Infection, the Centre of Excellence for Advanced Sciences, the National Research Centre, Giza 12311, Egypt; Environmental Virology Laboratory, Department of Water Pollution Research, Institute of Environmental Research and Climate Changes, the National Research Centre, Dokki, Giza 12311, Egypt.
Mahmoud Mohamed BahgatDepartment of Therapeutic Chemistry, Institute of Pharmaceutical and Drug Industries Research, the National Research Centre, Dokki, Giza 12311, Egypt; Research Group Immune- and Biomarkers for Infection, the Centre of Excellence for Advanced Sciences, the National Research Centre, Giza 12311, Egypt; Egypt Center for Research and Regenerative Medicine, Al Abbassia, Cairo 11517, Egypt. Electronic address: mbahgatriad@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSARS-CoV-2 enters human cells via angiotensin-converting enzyme 2 (ACE2). In silico experiments also demonstrated possible SARS-CoV-2 binding to dipeptidyl peptidase 4 (DPP-4) during cell entry. Moreover, matrix metalloproteinase 2 (MMP-2) is involved in the SARS-CoV-2 cell fusion process.

aimsTo study expression and activity profiles of implicated enzymes in SARS-CoV-2 infection in various age groups of both genders and discuss the possible impact of this on COVID-19 outcome.

methodsSaliva from different age groups was used to profile MMP-2 and gelatinase enzymes by zymography. Enzyme activities resulting from the cleavage of the H-Arg-Pro-pNA substrate were measured using a microplate reader. ACE2 transcription and translation were quantified using qRT-PCR and ELISA. Statistical analysis was used to identify the presence of significant differences.

resultsZymography demonstrated different gelatinase activities in a range of ∼180-30 kDa and showed distinct bands at ∼96, 72, 66, 60, and 40 kDa. Comparing MMP-2, DPP-4, DPP-4/ACE2 activities, ACE2 protein, and mRNA levels between genders showed p-values of 0.0142, 0.1056, 0.1859, 0.6411, and 0.4797, whereas correlations with age showed correlation coefficient (r) values of 0.1377, 0.4185, 0.0597, -0.0993, and -0.0073, respectively. The r values between ACE2 protein and ACE2 mRNA with DPP-4 activity were -0.0668 and 0.1935, respectively. The values between both DPP-4 activity and ACE2 protein with MMP-2 activity were -0.0506 and 0.0898, respectively. Results reflected (1) MMP-2 activity is higher among males. (2) DPP-4 activity positively correlates with age. (3) Gender differences in DPP-4 activity, ACE2 protein, and mRNA levels were not statistically significant. (4) Age differences in MMP-2 activity, ACE2 expression were not significant. (5) Inter-enzyme correlations were not observed.

conclusionsThe differential activity of both MMP-2 and DPP-4 highlights their potential as risk factors for susceptibility to SARS-CoV-2 infection and COVID-19 severity in males and older groups.

Indexed as

ActivitiesAngiotensin converting enzyme 2BiomarkerCOVID-19 severityDipeptidyl peptidase 4Matrix metalloproteases 2SARS-CoV-2

Identifiers

PMID40854629
PMCPMC12212272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.